[Prospective evaluation of pain induced by the transport of patients in the hospital: risk factors and proposal for improvement].

Abstract:

:Cancer patients are often moved inside the hospital to different examination clinics, such as radiology, CT scan, MRI... and to treatment clinics, such as radiotherapy. These transports induce important pain phenomena, not really recognized by professional teams. As these kinds of pains are expected and can be prevented, they must be included in quality of care increasing measures. For patients who experiment chronic pain, systematic pain assessment, preventive treatments and kind of transport must be taken into account.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Nebbak JM,Mathivon D,Di Palma M

doi

10.1684/bdc.2008.0638

subject

Has Abstract

pub_date

2008-05-01 00:00:00

pages

551-5

issue

5

eissn

0007-4551

issn

1769-6917

pii

bdc.2008.0638

journal_volume

95

pub_type

杂志文章
  • Factors controlling immunoglobulin production and B cell proliferation.

    abstract::The proliferation and the differentiation of B lymphocytes is under the control of T cell and macrophage produced cytokines which drive resting B cells to the state of antibody-producing plasma cells. Antibodies exert a feedback control of their own production via their interaction with Fc receptor (FcR) bearing cells...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fridman WH

    更新日期:1991-01-01 00:00:00

  • [Nomograms in routine clinical practice: Methodology, interest and limitations].

    abstract::In order to help the clinician, mathematical models including several clinical and pathological variables are proposed in the literature with the aim to predict the occurrence of an event of interest. Nomograms allow individual prognosis for each patient. When they are developed, validated and correctly used, nomogram...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.10.024

    authors: Filleron T,Chaltiel L,Jouve E,Cabarrou B,Gilhodes J,Lusque A,Mery E,Dalenc F,Martinez A

    更新日期:2018-01-01 00:00:00

  • [Target antigens for therapeutic antibodies in oncology: many candidates, few successes].

    abstract::Targeted therapies, especially monoclonal antibodies, have reached an increasing importance in oncology. High-throughput techniques have allowed the identification of numerous transcripts, proteins, or non-protein antigens, which have generated the concept of immunome. This epitope library constitutes a huge reservoir...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ceze N,Probst A,Lecomte T,Ohresser M,Paintaud G,Watier H

    更新日期:2007-01-01 00:00:00

  • [Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy].

    abstract::This study was performed in a group of 89 patients treated for breast carcinoma with a FEC regimen (5-fluorouracil, epirubicin, cyclophosphamide). The aim was to evaluate the antiemetic efficacy of one 8 mg tablet ondansetron (OND), and in case of failure, to measure the recovering level by the administration of 8 mg ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hebbar M,Hecquet B,Vanlemmens L,Lecomte S,Pion JM,Adenis A,Bonneterre J

    更新日期:1995-01-01 00:00:00

  • [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].

    abstract::Serotonin (5-Hydroxytryptamine) seems to play a dominant role in triggering vomiting induced by cytotoxic agents through the stimulation of 5-HT3 receptors. They have been observed in the GI tract as well as in the brain (area postrema). Ondansetron is a specific antagonist of 5-HT3 serotonin receptors. Its anti-emeti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: d'Allens H,Aubert B,Bons J,Pappo M

    更新日期:1991-01-01 00:00:00

  • [IMiDs in hematology].

    abstract::IMiDs belong to a new pharmalogical class, whose principal therapeutic agents are the thalidomide and the lenalidomide. They have immunomodulatory and antiangiogenic properties, as well as a direct effect on tumor cells. Thalidomide and lenalidomide were first approved for multiple myeloma, and in 5q-myelodysplastic s...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1404

    authors: Wémeau M,Gauthier J,Leleu X,Yakoub-Agha I

    更新日期:2011-08-01 00:00:00

  • [Ultrastructural study of 36 lymph node sites of Hodgkin's disease].

    abstract::The authors report their ultrastructural findings of 36 involved lymph-nodes in Hodgkin's disease (HD), before any treatment. More than 400 tumour cells were studied. An analytical study was carried out on the different aspects presented by the nuclei (uni or multi-lobated); the nucleoli (compact, reticulate or disper...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Diebold J,Reynes M,Marchal G,Tricottet V,Mrena E

    更新日期:1986-01-01 00:00:00

  • Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors.

    abstract::Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors were studied in order to assess the frequency, morbidity and characteristics of these complications. Thirty-three cases were investigated at the Institut Gustave-Roussy; 63 episodes of granulocytope...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ribrag V,Droz JP,Kattan J,Andremont A

    更新日期:1992-01-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [The cost of radiotherapy].

    abstract::The higher human and material costs induced by the development of conformal radiotherapy and other innovative techniques have to be evaluated. Different studies reflect benefit for three-dimensional conformal radiation therapy. This needs appropriate economic analyses (cost/benefit, cost/utility). Conclusions from stu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Martin P

    更新日期:2003-11-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Analysis of the growth kinetics of autochthonous DMBA-induced tumors in mice of various ages and sex].

    abstract::In order to understand the kinetics of this experimental model, we studied the influence of age and sex on primary tumoral and pulmonary metastatic yields and on the growth kinetics parameters. Connective tissue tumors were induced by DMBA in male and female Swiss mice of various ages (pre and postpubertal, adult and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vrignaud P,Denechaud M

    更新日期:1985-01-01 00:00:00

  • [The sentinel lymph node in carcinomas of the digestive tract].

    abstract::Localization of the sentinel lymph node (SLN) in digestive cancers was performed mainly for colorectal primaries and less frequently for oeso-gastric primaries. This technique is feasible in vivo or ex vivo, with a vital dye and/or with a radiolabeled marker. Technically, detection reliability is good, provided a few ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Elias D,Lasser P,Duvillard P

    更新日期:2002-06-01 00:00:00

  • [Squamous cell anal carcinoma. What's next ?]

    abstract::Despite its status as a rare disease, the incidence of the squamous cell carcinoma of the anus (SCCA) is surging, especially in its metastatic form. In addition, the prognosis of initially localized diseases has not substantially changed since the 1970s with a recurrence rate of between 25-40 % after the chemoradiothe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.12.001

    authors: Kim S,Spehner L,Cabel L,Bidard FC,Borg C

    更新日期:2021-01-01 00:00:00

  • [2 malignant cell lines derived from strain L6 of rat myogenic cells].

    abstract::A nonfusing variant M4 of the L6 line of rat myoblasts was isolated. This subline was tumorigenic when inoculated into suckling rats. Comparative studies of cells growth in vitro, serum requirement, cell adhesiveness and capacity to form colonies in soft agar confirmed that M4 cells had undergone neoplastic transforma...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hillion J,Leibovitch MP,Leibovitch SA,Harel J

    更新日期:1982-01-01 00:00:00

  • [Role of psychological factors in cancerogenesis and the development of cancerous disease].

    abstract::Psychoanalysts working in cancerology have to face three main difficulties concerning their methodology: the selection of representative populations, the identification of prospective factors and the choice and definition of the data they need to collect. Four examples are given hereafter: a prospective study on the p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Raimbault E

    更新日期:1986-01-01 00:00:00

  • [Participation to organized screening programs: Individual and collective stakes].

    abstract::The evaluation of the risk-benefit balance in public health is an ethical commitment, based on the imperative of not harming people. Screening is a probabilistic approach, which, in order to serve the needs of a few, involves the largest number to share the potential harmful effects. Improvement of scientific knowledg...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2018.04.008

    authors: Launoy G,Duchange N,Darquy S,Moutel G

    更新日期:2019-01-01 00:00:00

  • [Chemotherapy with high-dose cisplatin in brain metastasis of lung cancers].

    abstract::CDDP is one of the most active single drugs in non small cell lung carcinoma. High doses of 200 mg/m2 are well tolerated when fractionated doses are used over a period of 5 d. Twenty-four consecutive patients (male, age range 38-70 y) with brain metastasis of lung carcinoma were included in this study. The total dose ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Kleisbauer JP,Guerin JC,Arnaud A,Poirier R,Vesco D

    更新日期:1990-01-01 00:00:00

  • [Qualitative and collaborative research with cancer patients. Experience narratives of treatments for peritoneal carcinomatosis].

    abstract:UNLABELLED:This CORCAN study is concerned with the way patients hospitalised for peritoneal carcinosis perceive surgical treatment and hyperthermic intraperitoneal chemotherapy (HIPEC). OBJECTIVES:(1) To identify and analyse, using concepts of social representation and accounts of the illness, characteristics of the w...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.10.015

    authors: Durif-Bruckert C,Guilloux R,Guïoux A,Lasserre E,Goffette J,Régnier V

    更新日期:2016-02-01 00:00:00

  • [Cancer of the prostate: estrogen therapy].

    abstract::From 1941, estrogens are usually used in the treatment of prostatic carcinoma, wrongly in case of adjuvant hormonotherapy and exceedingly because of cardiovascular toxicity from over dosages. A recall of their mechanism of action and toxicity allows to argue about the palliative treatment and to look to their use for ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Richaud P,Mage P,Thomas L,Lamarche P

    更新日期:1986-01-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • Medical practices and cancer care networks: examples in oncology.

    abstract::Understanding medical practices or the whys and wherefores of care decision-making is among the major objectives of medical, economic and sociological research in the current political environment. Although variations of medical practice have long been known to exist, causes and deciding factors remain obscure. This i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ray-Coquard I,Chauvin F,Lurkin A,Ducimetière F,Jacquin JP,Agostini C,Pouchard I,Meyer B,Farsi F,Castel P,Perrier L,Philip T

    更新日期:2006-02-01 00:00:00

  • [Coordinated organization of symptoms management and support in all the stages of cancer disease: putting in place pluridisciplinary structures of supportive oncological care].

    abstract::The organization of the management of pain and other symptoms all along the cancer disease, of psychological support and palliative care is a complex question that does not correspond to any perfectly established model, both in France and abroad. Different structures are implied in there care and coexist with an insuf...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Krakowski I,Chardot C,Bey P,Guillemin F,Philip T

    更新日期:2001-03-01 00:00:00

  • [Leiomyosarcoma of the larynx. Review of the literature apropos of a case].

    abstract::Leiomyosarcoma of the larynx is extremely rare, only 21 cases were reported in the literature. The authors report a personal case in a 26 years old patient treated by a total laryngectomy and analyse all cases of the literature. It comes in relative young man (42 years old) in regard to the others ORL localisations. T...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Samlali R,Acharki A,Sahraoui S,Tihyfa M,Benider A,Kahlain A

    更新日期:1996-10-01 00:00:00

  • [The surrogate: Partner in the shared decision-making].

    abstract:UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.003

    authors: Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

    更新日期:2016-07-01 00:00:00

  • [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].

    abstract::The serious digestive side effects of the selective inhibitors the inducible cyclooxygenase-2 are reduced by 60% as compared to the nonselective non-steroidal anti-inflammatory drugs. The main risk factors associated with gastro-intestinal ulcers caused by the latter were found also with the selective inhibitors taken...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lamarque D

    更新日期:2004-05-01 00:00:00

  • [Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer].

    abstract::The tolerance and the clinical and histological efficacy of a neoadjuvant chemotherapy FEC-HD including hematopoietic growth factors have been studied in 40 patients with stade II or III breast cancer between February 1991 and February 1997. Four courses were given, every 21 days, with 5-fluorouracil (750 mg/m2/day D1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Darut-Jouve A,Coudert B,Jolimoy G,Belichard C,Arnoud L,Guerrin J

    更新日期:1999-02-01 00:00:00

  • [Small cell carcinoma. Incidence, histopathology and anatomical features. Analysis of 465 autopsied bronchopulmonary carcinomas (author's transl)].

    abstract::465 patients with broncho-pulmonary malignant tumors have been autopsied. Small cell carcinoma was diagnosed in 22.5 per cent of these patients. The histo-cytological variants of these tumors (lymphocytoid, polygonal, fusiform and polymorphic) had the same general characteristics (age, sex, survival) and a similar cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chomette G,Auriol M,Tranbaloc P,Esperandieu O,Guettier C

    更新日期:1982-01-01 00:00:00

  • [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].

    abstract::Glioblastoma multiforme still remains, at present, the most frequent and deadly primary malignant glioma in adult. Despite safer and larger neurosurgical resections, patients almost always relapse very close or inside the tumor bed. Since more than 20 years, radiation therapy (RT) continue delivering the same dose of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dhermain F,Ducreux D,Bidault F,Bruna A,Parker F,Roujeau T,Beaudre A,Armand JP,Haie-Meder C

    更新日期:2005-04-01 00:00:00

  • [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].

    abstract::For most diseases, one observes great variability in clinical course and response to therapy which should be taken into account in the design and the analysis of clinical trials. Eligibility criteria and stratified randomization use prognostic knowledge. A suitable analysis of randomized studies includes: (1) checking...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Byar D,Chastang C

    更新日期:1987-01-01 00:00:00